Citation: | JIANG Yaling, LI Ke, HUANG Wenlong, HU Guoqiang. Synthesis and antitumor activity of 3-(5-benzylidenethuzolo-triazlone)fluoroquinolones[J]. Journal of China Pharmaceutical University, 2018, 49(6): 671-675. DOI: 10.11665/j.issn.1000-5048.20180605 |
[1] |
Guo ZR.R&D based on pharmacophore and scaffold hopping for imrecoxib[J].Acta Pharm Sin(药学学报),2018,53(8):1383-1386.
|
[2] |
Hu W,Huang XS,Wu JF,et al.Discovery of novel topoisomerase II inhibitors by medicinal chemistry approaches[J].J Med Chem,2018,61(20):8947-8980.
|
[3] |
Zhang HL,Li K,Zhao H,et al.Synthesis and antitumor activity of fluoroquinolone C-3 s-triazole Schiff- base carboxylic acid derivatives from pefloxacin(X)[J].J China Pharm Univ(中国药科大学学报),2017,48(2):167-171.
|
[4] |
Yan Q,Ni LL,Wu SM,et al.Synthesis and antitumor activity of C-3 thiazolo [3,2-b][1,2,4] triazole substituted pefloxacin derivatives[J].J China Pharm Univ(中国药科大学学报).2015,46(5):548-551.
|
[5] |
Yang T,Wang XM,Wang R,et al.Synthesis and antitumor activity of pefloxacin C-3(rhodanine unsaturated ketone)amide derivatives[J].J China Pharm Univ(中国药科大学学报),2017,48(5):543-547.
|
[6] |
Song M.Progress in discovery of KIF5B-RET kinase inhibitors for the treatment of non-small-cell lung cancer[J].J Med Chem,2015,58(9):3672-3681.
|
[7] |
Zhuang CL,Zhang W,Sheng CQ,et al.Chalcone:a privileged structure in medicinal chemistry[J].Chem Rev,2017,117(12):7762-7810.
|
[8] |
Majumdar P,Pati A,Patra M,et al.Acid hydrazides,potent reagents for synthesis of oxygen-,nitrogen-,and/or sulfur-containing heterocyclic rings[J].Chem Rev,2014,114(5):2942-2977.
|